Evidence map›Paper›PMID 35184367›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2022

Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium.

Claire Sexton, Michele Solis, Judith Aharon-Peretz, Panagiotis Alexopoulos, Liana G Apostolova, Eléonore Bayen, Betty Birkenhager, Stefano Cappa, Fofi Constantinidou, Juan Fortea and 27 more

Abstract readReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Claire SextonAlzheimer's Association, 225 N Michigan Avenue, 17th Fl, Chicago, Illinois, USA.ORCID 0000-0002-3846-2986
Michele SolisFreelance science writer, Seattle, Washington, USA.
Judith Aharon-PeretzRambam Health Care Campus, Rappapaort School of Medicine, Haifa, Israel.
Panagiotis AlexopoulosDepartment of Psychiatry, Patras University Hospital, Faculty of Medicine, School of Health Sciences, University of Patras, Patras, Greece.
Liana G ApostolovaIndiana University, Bloomington, IN, USA.
Eléonore BayenLaboratoire d'imagerie biomédicale, Sorbonne Université, department of physical rehabilitation medicine, Pitié-Salpêtrière hospital, AP-HP, Paris, France.
Betty BirkenhagerDepartment of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Stefano CappaUniversity School for Advanced Studies (IUSS-Pavia) and IRCCS Mondino Foundation, Pavia, Italy.
Fofi ConstantinidouDepartment of Psychology & Center for Applied Neuroscience, University of Cyprus, Nicosia, Cyprus.
Juan ForteaSant Pau Memory Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau- Universitat Autònoma de Barcelona, Barcelona, Spain.
Debby L GerritsenRadboud Medical Center Nijmegen, Nijmegen, the Netherlands.
Hany I HassaninGlobal Brain Health Institute, University of California San Francisco, San Francisco, California, USA.
Agustin IbanezGlobal Brain Health Institute, University of California San Francisco, San Francisco, California, USA.
Panagiotis IoannidisAristotle University of Thessaloniki, Thessaloniki, Greece.
Elissaios KarageorgiouNeurological Institute of Athens, Athens, Greece.
Amos KorczynTel Aviv University, Tel Aviv, Israel.
Iracema LeroiTrinity College Dublin, Global Brain Health Institute, Dublin, Ireland.
Bjorn LichtwarckThe Centre for Age-related Functional Decline and Disease, Innlandet Hospital Trust, Ottestad, Norway.
Giancarlo LogroscinoCenter for Neurodegenerative Diseases and the Aging Brain Department of Clinical Research in Neurology of the University of Bari at "Pia Fondazione Card G. Panico" Hospital Tricase (Le), Bari, Italy.
Chris LynchAlzheimer's Disease International, London, UK.
Patrizia MecocciInstitute of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Jose Luis MolinuevoH Lundbeck A/S.
John PapatriantafyllouThird Age Center IASIS, Athens-Glyfada, Athens, Greece.
Sokratis Papegeorgiou1st University Neurology Department, Eginitio Hospital, Athens, Greece.
Antonis Politis1st Department of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.
Rema RamanAlzheimer's Therapeutic Research Institute, University of Southern California, CA, USA.
Karen RitchieINSERM, France.
Pascual Sanchez-JuanInstitute for Research Marqués de Valdecilla (IDIVAL), CIBERNED, University of Cantabria and Department of Neurology, Marqués de Valdecilla University Hospital, Santander, Spain.
Mary SanoThe Mount Sinai Hospital, New York, NY, USA.
Nikolas ScarmeasNational and Kapodistrian University of Athens, Athens, Greece.
Luiza SpiruCarol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania.
Afroditi StathiSchool of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.
Magda Tsolaki1st Department of Neurology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Greece.
Görsev YenerFaculty of Medicine, Izmir University of Economics, Izmir, Turkey.
Ioannis ZaganasNeurogenetics Laboratory, Medical School, University of Crete.
Stelios ZygourisCentre for Research and Technology Hellas/ Information Technologies Institute, Thessaloniki, Greece.
Maria CarrilloAlzheimer's Association, 225 N Michigan Avenue, 17th Fl, Chicago, Illinois, USA.

Funding

US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArT–HS)R01AG061111 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2019 to 2025
$3.6M
Tau pathology in Down syndrome and Alzheimer'sRF1AG061566 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER, MARGITTAI, MARTIN · 2019 to 2019
$3.4M
Biological Correlates of Alzheimer in Down Syndrome.R21AG056974 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER · 2017 to 2018
$414k
NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG061111NIA NIH HHS R21 AG056974NIA NIH HHS RF1 AG056850NIA NIH HHS RF1 AG061566
6 · The paper itself

Abstract

As research and services in the Mediterranean region continue to increase, so do opportunities for global collaboration. To support such collaborations, the Alzheimer's Association was due to hold its seventh Alzheimer's Association International Conference Satellite Symposium in Athens, Greece in 2021. Due to the COVID-19 pandemic, the meeting was held virtually, which enabled attendees from around the world to hear about research efforts in Greece and the surrounding Mediterranean countries. Research updates spanned understanding the biology of, treatments for, and care of people with Alzheimer's disease (AD_ and other dementias. Researchers in the Mediterranean region have outlined the local epidemiology of AD and dementia, and have identified regional populations that may expedite genetic studies. Development of biomarkers is expected to aid early and accurate diagnosis. Numerous efforts have been made to develop culturally specific interventions to both reduce risk of dementia, and to improve quality of life for people living with dementia.

Indexed as

Alzheimer DiseaseCOVID-19BiomarkersHumansPandemicsQuality of LifeBiomarkersAlzheimer's diseasebiomarkerscaredementiageneticsprevention

Identifiers

PMID35184367
PMCPMC11066754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.